Global law firm Hogan Lovells announced that Nicola Lemay has joined the firm’s Corporate & Finance practice as a partner in the Boston office. Lemay joins...
Hogan Lovells expands Boston footprint with addition of leading tax lawyer
Ginkgo Bioworks’ Collaboration Agreement with Pfizer
Foley Hoag LLP represented Ginkgo Bioworks on the agreement. Ginkgo Bioworks (NYSE: DNA) announced a collaboration with Pfizer (NYSE: PFE) focused on the discovery of RNA-based drug...
Daewoong’s $336 Million Licensing Agreement with CS Pharmaceuticals
Foley Hoag advised Daewoong Pharmaceutical on the deal. South Korea’s Daewoong Pharmaceutical (“Daewoong”) secured an exclusive licensing agreement with CS Pharmaceuticals, a UK based multinational company focused...
Alcyone’s License and Collaboration Agreement with Biogen Inc.
Foley Hoag LLP represented Alcyone Therapeutics on the deal. Alcyone Therapeutics (Alcyone) announced the negotiation of a license and collaboration agreement with Biogen Inc. (Nasdaq: BIIB) to...
Lantheus Holdings’ $575 Million Notes Offering
Foley Hoag LLP advised Lantheus Holdings, Inc. on the deal. Lantheus Holdings, Inc. (NASDAQ: LNTH) announced a Rule 144A offering of $575 million aggregate principal amount...
Ginkgo Bioworks’ Collaboration Agreement with Merck
Foley Hoag LLP represented Ginkgo Bioworks on the deal. Ginkgo Bioworks, Inc. (NYSE: DNA), the leading horizontal platform for cell programming, closed a collaboration agreement with...
Ginkgo Bioworks’ Collaboration with Novo Nordisk
Foley Hoag LLP represented Ginkgo Bioworks, Inc. on the deal. Ginkgo Bioworks, Inc. (NYSE: DNA), the leading horizontal platform for cell programming, closed a collaboration agreement with...
Intellia Therapeutics’ Acquisition of a Stake in SparingVision
IN BRIEF: Bird & Bird, Foley Hoag LLP, Goodwin Procter, advised on the matter. Bird & Bird advised SparingVision SAS with a team including Emmanuelle Porte...
Environmental Impact’s Business Combination with GreenLight Biosciences
Foley Hoag represented GreenLight., while Latham & Watkins represented Environmental Impact Acquisition Corp. in the transaction. GreenLight Biosciences, Inc., a biotechnology company dedicated to making ribonucleic acid...
FibroGen’s Partnership with HiFiBiO Therapeutics
Foley Hoag LLP advised HiFiBiO Therapeutics on the deal. FibroGen, Inc. (Nasdaq: FGEN) and HiFiBiO Therapeutics, a private, multinational clinical-stage biotherapeutics company with expertise in immune...
Ginkgo Bioworks’ Collaboration and License Agreement with Biogen
Foley Hoag LLP advised Ginkgo Bioworks on the deal. Ginkgo Bioworks, Inc., the organism company, closed a collaboration and license agreement with Biogen (Nasdaq: BIIB) to...
Ginkgo Bioworks’ Collaboration and License Agreement with Biogen
Foley Hoag LLP advised Ginkgo Bioworks on the deal. Ginkgo Bioworks, Inc., the organism company, closed a collaboration and license agreement with Biogen (Nasdaq: BIIB) to...